JOYCE MARTIN JOSEPH 4

4 · Aldeyra Therapeutics, Inc. · Filed Jun 11, 2020

Form 4

Period: 2020-06-09

Director

Transactions

Award
Stock Option (Right to Buy)
2020-06-09+26,503→ 26,503 total
Exercise: $5.02Exp: 2030-06-08→ Common Stock (26,503 underlying)
Award
Stock Option (Right to Buy)
2020-06-09+1,079→ 1,079 total
Exercise: $5.02Exp: 2030-06-08→ Common Stock (1,079 underlying)
Award
Stock Option (Right to Buy)
2020-06-09+4,623→ 4,623 total
Exercise: $5.02Exp: 2030-06-08→ Common Stock (4,623 underlying)

Footnotes (3)

[F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
[F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.
[F3]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.

Documents

1 file